While there is a lot of attention around drugs like Ozempic® and Moujaro®, it is important to keep a patient-centric perspective. Positive clinical outcomes are only achieved when the therapy is matched to the right individual and the individual is able to tolerate the therapy.

On May 22, 2024, IPM successfully submitted data in accordance with the Consolidated Appropriations Act, 2021 (CAA) ahead of the June 1 deadline.

Curious how we are handling reporting for 2023? Read on for more information.

With gratitude, we recognize the impact pharmacists have on our communities and organization because sometimes heroes wear white coats.

Learn how IPM can help your government sponsored behavioral health or county indigent health care program achieve its pharmacy benefit goals, like containing cost, expanding access to care and having on demand reporting.

Dr. Narus will be responsible for the overall strategy and execution of clinical operations, as well as the development and execution of new, innovative clinical programs.

IPM is honored to win a Silver Stevie® Award in the Employer of the Year category in the seventh annual Stevie Awards for Great Employers.

Have a trip coming up? Get the latest on traveling with your meds – from TSA guidelines to early refills and what to do if your meds are lost or stolen.

IPM is excited to be in the running for the Employer of the Year Awards hosted by the Stevie American Business Awards!